ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurostimulation and Neuromodulation Device Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-32N9342
Home | Market Reports | Health| Medical Devices & Equipment
Global Neurostimulation and Neuromodulation Device Market Insights and Forecast to 2028
BUY CHAPTERS

Global Neurostimulation and Neuromodulation Device Market Research Report 2025

Code: QYRE-Auto-32N9342
Report
August 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Axogen
Baxter
Boston Scientific
LivaNova
Integra LifeSciences
Medtronic Inc
Abbott Laboratories
Stryker
Polyganics
Nuvectra
NeuroPace Inc
Orthomed
Nevro

Neurostimulation and Neuromodulation Device Market

The global market for Neurostimulation and Neuromodulation Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Neurostimulation and Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Neurostimulation and Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Neurostimulation and Neuromodulation Device include Axogen, Baxter, Boston Scientific, Livanova, Integra Lifesciences, Medtronic, Abbott Laboratories, Stryker, Polyganics, Nuvectra, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurostimulation and Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurostimulation and Neuromodulation Device.
The Neurostimulation and Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurostimulation and Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurostimulation and Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neurostimulation and Neuromodulation Device Market Report

Report Metric Details
Report Name Neurostimulation and Neuromodulation Device Market
Segment by Type
  • Internal
  • External
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Axogen, Baxter, Boston Scientific, Livanova, Integra Lifesciences, Medtronic, Abbott Laboratories, Stryker, Polyganics, Nuvectra, Neuropace, Orthomed, Nevro
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurostimulation and Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurostimulation and Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Neurostimulation and Neuromodulation Device Market report?

Ans: The main players in the Neurostimulation and Neuromodulation Device Market are Axogen, Baxter, Boston Scientific, Livanova, Integra Lifesciences, Medtronic, Abbott Laboratories, Stryker, Polyganics, Nuvectra, Neuropace, Orthomed, Nevro

What are the Application segmentation covered in the Neurostimulation and Neuromodulation Device Market report?

Ans: The Applications covered in the Neurostimulation and Neuromodulation Device Market report are Hospitals and clinics, Ambulatory Surgery Center

What are the Type segmentation covered in the Neurostimulation and Neuromodulation Device Market report?

Ans: The Types covered in the Neurostimulation and Neuromodulation Device Market report are Internal, External

Recommended Reports

Neurostimulation Devices

Neurovascular Devices

Stimulation & Monitoring

1 Neurostimulation and Neuromodulation Device Market Overview
1.1 Product Definition
1.2 Neurostimulation and Neuromodulation Device by Type
1.2.1 Global Neurostimulation and Neuromodulation Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Internal
1.2.3 External
1.3 Neurostimulation and Neuromodulation Device by Application
1.3.1 Global Neurostimulation and Neuromodulation Device Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and clinics
1.3.3 Ambulatory Surgery Center
1.4 Global Neurostimulation and Neuromodulation Device Market Size Estimates and Forecasts
1.4.1 Global Neurostimulation and Neuromodulation Device Revenue 2020-2031
1.4.2 Global Neurostimulation and Neuromodulation Device Sales 2020-2031
1.4.3 Global Neurostimulation and Neuromodulation Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neurostimulation and Neuromodulation Device Market Competition by Manufacturers
2.1 Global Neurostimulation and Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neurostimulation and Neuromodulation Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neurostimulation and Neuromodulation Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neurostimulation and Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Product Type & Application
2.7 Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Date of Enter into This Industry
2.8 Global Neurostimulation and Neuromodulation Device Market Competitive Situation and Trends
2.8.1 Global Neurostimulation and Neuromodulation Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurostimulation and Neuromodulation Device Players Market Share by Revenue
2.8.3 Global Neurostimulation and Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurostimulation and Neuromodulation Device Market Scenario by Region
3.1 Global Neurostimulation and Neuromodulation Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neurostimulation and Neuromodulation Device Sales by Region: 2020-2031
3.2.1 Global Neurostimulation and Neuromodulation Device Sales by Region: 2020-2025
3.2.2 Global Neurostimulation and Neuromodulation Device Sales by Region: 2026-2031
3.3 Global Neurostimulation and Neuromodulation Device Revenue by Region: 2020-2031
3.3.1 Global Neurostimulation and Neuromodulation Device Revenue by Region: 2020-2025
3.3.2 Global Neurostimulation and Neuromodulation Device Revenue by Region: 2026-2031
3.4 North America Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.4.1 North America Neurostimulation and Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neurostimulation and Neuromodulation Device Sales by Country (2020-2031)
3.4.3 North America Neurostimulation and Neuromodulation Device Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.5.1 Europe Neurostimulation and Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neurostimulation and Neuromodulation Device Sales by Country (2020-2031)
3.5.3 Europe Neurostimulation and Neuromodulation Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurostimulation and Neuromodulation Device Market Facts & Figures by Region
3.6.1 Asia Pacific Neurostimulation and Neuromodulation Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neurostimulation and Neuromodulation Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.7.1 Latin America Neurostimulation and Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neurostimulation and Neuromodulation Device Sales by Country (2020-2031)
3.7.3 Latin America Neurostimulation and Neuromodulation Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurostimulation and Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neurostimulation and Neuromodulation Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neurostimulation and Neuromodulation Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurostimulation and Neuromodulation Device Sales by Type (2020-2031)
4.1.1 Global Neurostimulation and Neuromodulation Device Sales by Type (2020-2025)
4.1.2 Global Neurostimulation and Neuromodulation Device Sales by Type (2026-2031)
4.1.3 Global Neurostimulation and Neuromodulation Device Sales Market Share by Type (2020-2031)
4.2 Global Neurostimulation and Neuromodulation Device Revenue by Type (2020-2031)
4.2.1 Global Neurostimulation and Neuromodulation Device Revenue by Type (2020-2025)
4.2.2 Global Neurostimulation and Neuromodulation Device Revenue by Type (2026-2031)
4.2.3 Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2020-2031)
4.3 Global Neurostimulation and Neuromodulation Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neurostimulation and Neuromodulation Device Sales by Application (2020-2031)
5.1.1 Global Neurostimulation and Neuromodulation Device Sales by Application (2020-2025)
5.1.2 Global Neurostimulation and Neuromodulation Device Sales by Application (2026-2031)
5.1.3 Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2020-2031)
5.2 Global Neurostimulation and Neuromodulation Device Revenue by Application (2020-2031)
5.2.1 Global Neurostimulation and Neuromodulation Device Revenue by Application (2020-2025)
5.2.2 Global Neurostimulation and Neuromodulation Device Revenue by Application (2026-2031)
5.2.3 Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2020-2031)
5.3 Global Neurostimulation and Neuromodulation Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Axogen
6.1.1 Axogen Company Information
6.1.2 Axogen Description and Business Overview
6.1.3 Axogen Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Axogen Neurostimulation and Neuromodulation Device Product Portfolio
6.1.5 Axogen Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Neurostimulation and Neuromodulation Device Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Company Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boston Scientific Neurostimulation and Neuromodulation Device Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Livanova
6.4.1 Livanova Company Information
6.4.2 Livanova Description and Business Overview
6.4.3 Livanova Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Livanova Neurostimulation and Neuromodulation Device Product Portfolio
6.4.5 Livanova Recent Developments/Updates
6.5 Integra Lifesciences
6.5.1 Integra Lifesciences Company Information
6.5.2 Integra Lifesciences Description and Business Overview
6.5.3 Integra Lifesciences Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Integra Lifesciences Neurostimulation and Neuromodulation Device Product Portfolio
6.5.5 Integra Lifesciences Recent Developments/Updates
6.6 Medtronic
6.6.1 Medtronic Company Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Medtronic Neurostimulation and Neuromodulation Device Product Portfolio
6.6.5 Medtronic Recent Developments/Updates
6.7 Abbott Laboratories
6.7.1 Abbott Laboratories Company Information
6.7.2 Abbott Laboratories Description and Business Overview
6.7.3 Abbott Laboratories Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Laboratories Neurostimulation and Neuromodulation Device Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Stryker
6.8.1 Stryker Company Information
6.8.2 Stryker Description and Business Overview
6.8.3 Stryker Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Stryker Neurostimulation and Neuromodulation Device Product Portfolio
6.8.5 Stryker Recent Developments/Updates
6.9 Polyganics
6.9.1 Polyganics Company Information
6.9.2 Polyganics Description and Business Overview
6.9.3 Polyganics Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Polyganics Neurostimulation and Neuromodulation Device Product Portfolio
6.9.5 Polyganics Recent Developments/Updates
6.10 Nuvectra
6.10.1 Nuvectra Company Information
6.10.2 Nuvectra Description and Business Overview
6.10.3 Nuvectra Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nuvectra Neurostimulation and Neuromodulation Device Product Portfolio
6.10.5 Nuvectra Recent Developments/Updates
6.11 Neuropace
6.11.1 Neuropace Company Information
6.11.2 Neuropace Description and Business Overview
6.11.3 Neuropace Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Neuropace Neurostimulation and Neuromodulation Device Product Portfolio
6.11.5 Neuropace Recent Developments/Updates
6.12 Orthomed
6.12.1 Orthomed Company Information
6.12.2 Orthomed Description and Business Overview
6.12.3 Orthomed Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Orthomed Neurostimulation and Neuromodulation Device Product Portfolio
6.12.5 Orthomed Recent Developments/Updates
6.13 Nevro
6.13.1 Nevro Company Information
6.13.2 Nevro Description and Business Overview
6.13.3 Nevro Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nevro Neurostimulation and Neuromodulation Device Product Portfolio
6.13.5 Nevro Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurostimulation and Neuromodulation Device Industry Chain Analysis
7.2 Neurostimulation and Neuromodulation Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurostimulation and Neuromodulation Device Production Mode & Process Analysis
7.4 Neurostimulation and Neuromodulation Device Sales and Marketing
7.4.1 Neurostimulation and Neuromodulation Device Sales Channels
7.4.2 Neurostimulation and Neuromodulation Device Distributors
7.5 Neurostimulation and Neuromodulation Device Customer Analysis
8 Neurostimulation and Neuromodulation Device Market Dynamics
8.1 Neurostimulation and Neuromodulation Device Industry Trends
8.2 Neurostimulation and Neuromodulation Device Market Drivers
8.3 Neurostimulation and Neuromodulation Device Market Challenges
8.4 Neurostimulation and Neuromodulation Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Axogen
Baxter
Boston Scientific
LivaNova
Integra LifeSciences
Medtronic Inc
Abbott Laboratories
Stryker
Polyganics
Nuvectra
NeuroPace Inc
Orthomed
Nevro
List of Tables
 Table 1. Global Neurostimulation and Neuromodulation Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Neurostimulation and Neuromodulation Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Neurostimulation and Neuromodulation Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Neurostimulation and Neuromodulation Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Neurostimulation and Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Neurostimulation and Neuromodulation Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Neurostimulation and Neuromodulation Device Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Neurostimulation and Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Product Type & Application
 Table 12. Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neurostimulation and Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurostimulation and Neuromodulation Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neurostimulation and Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Neurostimulation and Neuromodulation Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Neurostimulation and Neuromodulation Device Sales Market Share by Region (2020-2025)
 Table 19. Global Neurostimulation and Neuromodulation Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Neurostimulation and Neuromodulation Device Sales Market Share by Region (2026-2031)
 Table 21. Global Neurostimulation and Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Neurostimulation and Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Neurostimulation and Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Neurostimulation and Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Neurostimulation and Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Neurostimulation and Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Neurostimulation and Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Neurostimulation and Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Neurostimulation and Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Neurostimulation and Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Neurostimulation and Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Neurostimulation and Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Neurostimulation and Neuromodulation Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Neurostimulation and Neuromodulation Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Neurostimulation and Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Neurostimulation and Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Neurostimulation and Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Neurostimulation and Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Neurostimulation and Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Neurostimulation and Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Neurostimulation and Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Neurostimulation and Neuromodulation Device Sales Market Share by Type (2020-2025)
 Table 53. Global Neurostimulation and Neuromodulation Device Sales Market Share by Type (2026-2031)
 Table 54. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2020-2025)
 Table 63. Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2026-2031)
 Table 64. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Application (2026-2031)
 Table 70. Axogen Company Information
 Table 71. Axogen Description and Business Overview
 Table 72. Axogen Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Axogen Neurostimulation and Neuromodulation Device Product
 Table 74. Axogen Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Baxter Neurostimulation and Neuromodulation Device Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. Boston Scientific Company Information
 Table 81. Boston Scientific Description and Business Overview
 Table 82. Boston Scientific Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Boston Scientific Neurostimulation and Neuromodulation Device Product
 Table 84. Boston Scientific Recent Developments/Updates
 Table 85. Livanova Company Information
 Table 86. Livanova Description and Business Overview
 Table 87. Livanova Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Livanova Neurostimulation and Neuromodulation Device Product
 Table 89. Livanova Recent Developments/Updates
 Table 90. Integra Lifesciences Company Information
 Table 91. Integra Lifesciences Description and Business Overview
 Table 92. Integra Lifesciences Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Integra Lifesciences Neurostimulation and Neuromodulation Device Product
 Table 94. Integra Lifesciences Recent Developments/Updates
 Table 95. Medtronic Company Information
 Table 96. Medtronic Description and Business Overview
 Table 97. Medtronic Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Medtronic Neurostimulation and Neuromodulation Device Product
 Table 99. Medtronic Recent Developments/Updates
 Table 100. Abbott Laboratories Company Information
 Table 101. Abbott Laboratories Description and Business Overview
 Table 102. Abbott Laboratories Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Abbott Laboratories Neurostimulation and Neuromodulation Device Product
 Table 104. Abbott Laboratories Recent Developments/Updates
 Table 105. Stryker Company Information
 Table 106. Stryker Description and Business Overview
 Table 107. Stryker Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Stryker Neurostimulation and Neuromodulation Device Product
 Table 109. Stryker Recent Developments/Updates
 Table 110. Polyganics Company Information
 Table 111. Polyganics Description and Business Overview
 Table 112. Polyganics Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Polyganics Neurostimulation and Neuromodulation Device Product
 Table 114. Polyganics Recent Developments/Updates
 Table 115. Nuvectra Company Information
 Table 116. Nuvectra Description and Business Overview
 Table 117. Nuvectra Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Nuvectra Neurostimulation and Neuromodulation Device Product
 Table 119. Nuvectra Recent Developments/Updates
 Table 120. Neuropace Company Information
 Table 121. Neuropace Description and Business Overview
 Table 122. Neuropace Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Neuropace Neurostimulation and Neuromodulation Device Product
 Table 124. Neuropace Recent Developments/Updates
 Table 125. Orthomed Company Information
 Table 126. Orthomed Description and Business Overview
 Table 127. Orthomed Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Orthomed Neurostimulation and Neuromodulation Device Product
 Table 129. Orthomed Recent Developments/Updates
 Table 130. Nevro Company Information
 Table 131. Nevro Description and Business Overview
 Table 132. Nevro Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Nevro Neurostimulation and Neuromodulation Device Product
 Table 134. Nevro Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Neurostimulation and Neuromodulation Device Distributors List
 Table 138. Neurostimulation and Neuromodulation Device Customers List
 Table 139. Neurostimulation and Neuromodulation Device Market Trends
 Table 140. Neurostimulation and Neuromodulation Device Market Drivers
 Table 141. Neurostimulation and Neuromodulation Device Market Challenges
 Table 142. Neurostimulation and Neuromodulation Device Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neurostimulation and Neuromodulation Device
 Figure 2. Global Neurostimulation and Neuromodulation Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neurostimulation and Neuromodulation Device Market Share by Type: 2024 & 2031
 Figure 4. Internal Product Picture
 Figure 5. External Product Picture
 Figure 6. Global Neurostimulation and Neuromodulation Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Neurostimulation and Neuromodulation Device Market Share by Application: 2024 & 2031
 Figure 8. Hospitals and clinics
 Figure 9. Ambulatory Surgery Center
 Figure 10. Global Neurostimulation and Neuromodulation Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Neurostimulation and Neuromodulation Device Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Neurostimulation and Neuromodulation Device Sales (2020-2031) & (K Units)
 Figure 13. Global Neurostimulation and Neuromodulation Device Average Price (USD/Unit) & (2020-2031)
 Figure 14. Neurostimulation and Neuromodulation Device Report Years Considered
 Figure 15. Neurostimulation and Neuromodulation Device Sales Share by Manufacturers in 2024
 Figure 16. Global Neurostimulation and Neuromodulation Device Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Neurostimulation and Neuromodulation Device Players: Market Share by Revenue in Neurostimulation and Neuromodulation Device in 2024
 Figure 18. Neurostimulation and Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Neurostimulation and Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Neurostimulation and Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 21. North America Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Neurostimulation and Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 25. Europe Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Neurostimulation and Neuromodulation Device Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2020-2031)
 Figure 33. China Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Neurostimulation and Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Neurostimulation and Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Neurostimulation and Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Neurostimulation and Neuromodulation Device by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Neurostimulation and Neuromodulation Device by Type (2020-2031)
 Figure 55. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Neurostimulation and Neuromodulation Device by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Neurostimulation and Neuromodulation Device by Application (2020-2031)
 Figure 58. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Application (2020-2031)
 Figure 59. Neurostimulation and Neuromodulation Device Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Neurostimulator Device Market Research Report 2025
Global Sacral Neuromodulation Device Market Research Report 2024
Global Tibial Neuromodulation Devices Market Research Report 2024
Internal Neuromodulation Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurostimulator Medical Device Market Research Report 2024
Global Neuro Stimulation Equipment Market Research Report 2024
Global Neurostimulator Market Research Report 2025
Neuromodulation Devices and Implantable Infusion Pumps Market
Global External Neuromodulation Market Research Report 2024
Global Spinal Cord Neurostimulation Implant Market Research Report 2025
Global Neuromodulation Sensor Market Research Report 2025
Global Transcutaneous Neurostimulators Market Research Report 2024
Global Peripheral Neurostimulator System Market Research Report 2025
Global Implantable Neuromodulation Device Market Research Report 2025
Global Interventional Neurological Devices Market Research Report 2024
Global Rechargeable Implantable Spinal Cord Neurostimulator Market Research Report 2024
Global Vagus Nerve Stimulation Devices Market Research Report 2025
Global Electrical Stimulation Devices Market Research Report 2024
Global Neurostimulation Systems Market Research Report 2024
Implantable Neurostimulation Devices Market

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions